ReviewHuman vaccines & immunotherapeutics2026
Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review.
Marn Joon Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.